معرفی
Prof. Dr. Constanze Schmidt is a Clinician-Scientist Professor (W3) at Heidelberg University, leading the Atrial Arrhythmopathy and Cellular Electrophysiology Group. She holds positions as Senior Physician at the Department of Cardiology, Angiology, and Pulmonology and the Heidelberg Center for Cardiac Arrhythmias. Her academic career includes habilitation at Heidelberg University and postdoctoral programs such as the Olympia-Morata Habilitationsprogramm. She specializes in molecular and translational electrophysiology, focusing on atrial fibrillation mechanisms and antiarrhythmic therapies.
Education includes a Medical Degree from Georg-August-Universität Göttingen and a PhD in Molecular Physiology. Her research integrates clinical electrophysiology with ion channel biology, exploring gene therapy and pharmacological interventions for arrhythmias. Notable grants include DFG funding and support from the Else-Kröner-Fresenius Foundation.
Research interests span atrial cardiomyopathy, TASK-1 channel inhibition, and translational models of arrhythmogenesis. Key achievements include patents on TASK-1 inhibitors and AAV-mediated gene therapy for atrial arrhythmias. Awards highlight her contributions to cardiac electrophysiology, including the Scientist of Tomorrow title from the European Society of Cardiology.
Professional memberships include the Deutsche Gesellschaft für Kardiologie (DGK) and European Society of Cardiology (ESC). Her work bridges basic science and clinical applications, aiming to develop precision therapies for heart rhythm disorders.
